These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15306750)

  • 21. Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis.
    Villa P; Aznar J; Vaya A; España F; Ferrando F; Mira Y; Estellés A
    Thromb Haemost; 1999 Sep; 82(3):1011-4. PubMed ID: 10494755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minor events and the risk of deep venous thrombosis.
    Eekhoff EM; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 2000 Mar; 83(3):408-11. PubMed ID: 10744145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes.
    Lombardi AM; Bortoletto E; Scarparo P; Scapin M; Santarossa L; Girolami A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):639-43. PubMed ID: 18832903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency.
    Ishii K; Oguchi S; Moriki T; Yatabe Y; Takeshita E; Murata M; Ikeda Y; Watanabe K
    Blood Coagul Fibrinolysis; 2004 Jul; 15(5):367-73. PubMed ID: 15205584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
    Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
    Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is factor XII deficiency related to recurrent miscarriage?
    Matsuura T; Kobayashi T; Asahina T; Kanayama N; Terao T
    Semin Thromb Hemost; 2001; 27(2):115-20. PubMed ID: 11372764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study.
    Girolami A; Ferrari S; Cosi E; Randi ML
    Blood Cells Mol Dis; 2019 Jul; 77():8-11. PubMed ID: 30884321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No impact of endogenous prothrombotic conditions on the risk of central venous line-related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis).
    Thom K; Male C; Mannhalter C; Quehenberger P; Mlczoch E; Luckner D; Marx M; Hanslik A
    J Thromb Haemost; 2014 Oct; 12(10):1610-5. PubMed ID: 25131188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of two novel mutations (Q421 K and R123P) in congenital factor XII deficiency.
    Kanaji T; Kanaji S; Osaki K; Kuroiwa M; Sakaguchi M; Mihara K; Niho Y; Okamura T
    Thromb Haemost; 2001 Dec; 86(6):1409-15. PubMed ID: 11776307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor XII clotting activity and antigen levels in patients with thromboembolic disease.
    von Känel R; Wuillemin WA; Furlan M; Lämmle B
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):555-61. PubMed ID: 1450322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor XII Ofunato: Lys346Asn mutation associated with blood coagulation factor XII deficiency causes impaired secretion through a proteasome-mediated degradation.
    Suzuki K; Murai K; Suwabe A; Ishida Y
    Thromb Res; 2010 May; 125(5):438-43. PubMed ID: 20022356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombosis in subjects with homozygous and heterozygous factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Tosetto A
    Thromb Haemost; 1992 May; 67(5):590-1. PubMed ID: 1519222
    [No Abstract]   [Full Text] [Related]  

  • 37. Association after linkage analysis indicates that homozygosity for the 46C-->T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis.
    Tirado I; Soria JM; Mateo J; Oliver A; Souto JC; Santamaria A; Felices R; Borrell M; Fontcuberta J
    Thromb Haemost; 2004 May; 91(5):899-904. PubMed ID: 15116249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel missense mutation in the factor XII gene in a litter of cats with factor XII deficiency.
    Maruyama H; Hosoe H; Nagamatsu K; Kano R; Kamata H
    J Vet Med Sci; 2017 May; 79(5):822-826. PubMed ID: 28392508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of coagulation factor XII in unexplained recurrent abortions in the Greek population.
    Dendrinos S; Deliveliotou A; Anastasiou A; Creatsas GK
    J Reprod Med; 2014; 59(1-2):56-62. PubMed ID: 24597288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
    Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.